Adding genetic NF2 screening to the standard methods of using fluorescence in situ hybridization (FISH) techniques to identify CDKN2A (p16Ink4a/p14Arf) deletions did not significantly improve the sensitivity or specificity of MM diagnosis. This evidence concerns the gene NF2 and Miyoshi myopathy.